111 patents
Utility
Method for diagnosis and/or prognosis of a septic syndrome
21 Nov 23
Disclosed herein is a method for the diagnosis/prognosis of a septic syndrome based on a biological sample from a patient.
Alexandre Pachot, Guillaume Monneret, Alain Lepape
Filed: 12 Mar 21
Utility
Optical density instrument and systems and methods using the same
10 Oct 23
Instruments, systems, and methods for measuring optical density of microbiological samples are provided.
Perry D. Stamm, Joel Patrick Harrison, Gregory R Maes, Jeffrey Edward Price, Jack R. Hoffmann, Jr., John Kenneth Korte, Daniel Joseph Pingel, Walter J. Clynes, Sean Gregory Furman, Leonard H. Schleicher, Christopher George Kocher, Brian David Peterson, Jacky S. Yam
Filed: 9 Sep 21
Utility
Method for measuring the plasma concentration of an analyte directly on a whole blood sample
5 Sep 23
A method of measuring an analyte amount in a whole blood sample, including (i) measuring the haematocrit level of the whole blood sample; (ii) measuring an analyte amount directly in the whole blood sample; and (iii) calculating a corrected analyte amount according to relation DP=Pa(DST, DH), where Dp, is the corrected analyte amount, DST is the measured analyte amount, DH is the measured haematocrit level, and Pa is a non-constant polynomial of a degree greater than or equal to 1 having as indeterminate values the measured analyte amount, DST, and the measured haematocrit level, DH, and having its polynomial coefficients depending on the analyte.
Sylvie Cheucle, Laure Marillet, Aurélie Thollet
Filed: 24 Oct 18
Utility
Sample test cards
22 Aug 23
The present invention is directed to sample test cards having an increased sample well capacity for analyzing biological or other test samples.
Bruno Colin, Raymond O'Bear, Cecile Paris
Filed: 18 Feb 19
Utility
Methods for confirming charged-particle generation in an instrument, and related instruments
2 May 23
Methods for confirming charged-particle generation in an instrument are provided.
James Arthur VanGordon
Filed: 25 Jan 21
Utility
Methods for aligning a light source of an instrument, and related instruments
14 Mar 23
Methods for an instrument including a light source of are provided.
Ian MacGregor, Scott Collins, Jo-ann Loh, Spencer Lovette, Andrew J. Violette, James VanGordon, Jared Bullock
Filed: 12 Mar 19
Utility
Assay devices and methods of manufacture
28 Feb 23
Systems, methods, and apparatuses are provided for self-contained nucleic acid preparation, amplification, and analysis.
Aaron Wernerehl, Jonathan A. Bruns, Jonathan B. Derrick, Taylor S. Zimmerman, David E. Jones
Filed: 28 Oct 20
Utility
Sample handling systems, mass spectrometers and related methods
28 Feb 23
Slide analysis a gripper with three sensors for controlling a slide grip sequence and at least one rotatable carousel with a slide receiving channel.
Jared Bullock, Scott Collins, Ian MacGregor, Mark Talmer
Filed: 10 May 21
Utility
Method for identifying by mass spectrometry an unknown microorganism subgroup from a set of reference subgroups
24 Jan 23
A method for identifying by mass spectrometry an unknown microorganism subgroup among a set of reference subgroups, including a step of constructing one knowledgebase and one classifying model per associated subgroup on the basis of the acquisition of at least one set of learning spectra of microorganisms identified as belonging to the subgroups of a group and including: constructing an adjusting model allowing mass-to-charge offsets of the acquired spectra to be corrected on the basis of reference masses-to-charges that are common to the various subgroups; adjusting the masses-to-charges of all of the lists of peaks of the learning spectra and constructing one classifying model per subgroup and the associated knowledgebase on the basis of the adjusted learning spectra.
Maud Arsac, Pierre-Jean Cotte-Pattat, Victoria Girard, Valérie Monnin
Filed: 21 Apr 16
Utility
Method for the diagnosis or prognosis, in vitro, of lung cancer
6 Dec 22
The subject matter of the present invention is a method for the diagnosis or prognosis, in vitro, of lung cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, a method for use of said nucleic acid sequences, which have been isolated, as a molecular marker or molecular markers, and a kit including at least one binding partner specific for at least one of the expression products of the HERV nucleic acid sequences.
Philippe Perot, François Mallet, Cécile Montgiraud, Nathalie Mugnier
Filed: 20 Dec 12
Utility
Method for the diagnosis or prognosis, in vitro, of testicular cancer
18 Oct 22
The subject matter of the present invention is a method for the diagnosis or prognosis, in vitro, of testicular cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said nucleic acid sequences, which have been isolated, as a molecular marker or molecular markers, and a kit including at least one binding partner specific for at least one of the expression products of the HERV nucleic acid sequences.
Philippe Perot, François Mallet, Nathalie Mugnier
Filed: 20 Dec 12
Utility
Method for the diagnosis or prognosis, in vitro, of prostate cancer
4 Oct 22
The present invention relates to a method for the in vitro diagnosis or prognosis of prostate cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said nucleic acid sequences, once isolated, as one or more molecular marker(s) and a kit comprising at least one specific binding partner of at least one of the expression products of the HERV nucleic acid sequences.
François Mallet, Nathalie Mugnier, Philippe Perot
Filed: 18 Dec 12
Utility
Method for in vitro diagnosis or prognosis of colon cancer
27 Sep 22
The present invention relates to a method for in vitro diagnosis or prognosis of colon cancer, including a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said isolated nucleic acid sequences as a molecular marker/molecular markers, and a kit including at least one specific binding partner for at least one expression product of the HERV nucleic acid sequences.
François Mallet, Nathalie Mugnier, Philippe Perot
Filed: 17 Dec 12
Utility
Method for the in vitro diagnosis or prognosis of ovarian cancer
27 Sep 22
The present invention relates to a method for the in vitro diagnosis or prognosis of ovarian cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said nucleic acid sequences, once isolated, as one or more molecular marker(s) and a kit including at least one specific binding partner of at least one of the expression products of the HERV nucleic acid sequences.
Philippe Perot, François Mallet, Nathalie Mugnier
Filed: 19 Dec 12
Utility
Isolation tube with an endcap
13 Sep 22
A separation container for extracting a portion of a sample for use or testing and method for preparing samples for downstream use or testing are provided.
Christopher S. Ronsick, Mark S. Wilson, John D. Walsh
Filed: 26 Jul 18
Utility
Sample test cards
13 Sep 22
The present invention is directed to sample test cards having an increased sample well capacity for analyzing biological or other test samples.
Raymond O'Bear, Brian Livingston, David Hertlein, Richard Scott Remes, Stanley Philipak
Filed: 2 Nov 17
Utility
Automated system for the lysis of microorganisms present in a sample, for extraction and for purification of the nucleic acids of said microorganisms for purposes of analysis
30 Aug 22
A method for collecting microorganisms when contained in a fluid includes (i) introducing the fluid into a cavity of a collecting device via at least one admission duct, (ii) capturing the microorganisms when contained in the fluid with a set of beads retained in the cavity as the fluid passes through the set of beads, (iii) evacuating the fluid from the cavity via at least one evacuating duct, (iv) introducing a reaction liquid into the cavity via at least one admission channel, (v) collecting the microorganisms from the set of beads with the reaction liquid as the reaction liquid passes through the set of beads, and (vi) evacuating the reaction liquid from the cavity via at least one evacuating channel.
Michel Guy, Hervé Rostaing
Filed: 21 Feb 20
Utility
Method and device for characterizing the inhibitory capacity of a molecule on a microorganism
16 Aug 22
A method for determining a quantity Ginhib quantifying the inhibitory capacity of a molecule on a type of microorganism includes: preparing a plurality of samples, including microorganisms of the type, a nutrient medium for the microorganism and an initial amount of the molecule per microorganism increasing in a range [Qmin,Qmax] as a function of a classification of the samples; measuring the growth of the microorganisms in the samples as a function of time; and determining the quantity Ginhib as a function of the measurements of the growth.
Maud Tournoud, Pierre Mahe
Filed: 30 Nov 15
Utility
Antibacterial compound and uses of same
16 Aug 22
Rosaleen Anderson, Mark Gray, Laszlo Kondacs, Sylvain Orenga, John Perry
Filed: 24 Sep 18
Utility
Detection instruments with automated cell location selection for newly intaken specimen containers and related methods
9 Aug 22
Automated test instruments electronically determine and/or obtain cell availability of cells of a holding structure in an incubated test chamber and for each of a plurality of open and available cells and electronically identify neighboring cells, electronically determining whether each of the identified neighboring cells are occupied or empty and, if occupied, electronically evaluating at least one of a test status or a time from load of a specimen container held therein.
Michael Edmiston, Jonathan Elenkiwich, Warren Vincent
Filed: 21 Aug 19